NAS:MEDP (USA) Also trade in: Germany Mexico

Medpace Holdings Inc

$ 62.38 -0.76 (-1.2%)
Volume: 243,481 Avg Vol (1m): 361,780
Market Cap $: 2.23 Bil Enterprise Value $: 2.26 Bil
P/E (TTM): 29.80 P/B: 3.68
Earnings Power Value 0
Net Current Asset Value -5.42
Tangible Book -2.78
Projected FCF 0
Median P/S Value 60.13
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 7.5/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.54
Cash-To-Debt range over the past 10 years
Min: 0.04, Med: 0.13, Max: 0.54
Current: 0.54
0.04
0.54
Equity-to-Asset 0.62
Equity-to-Asset range over the past 10 years
Min: 0.42, Med: 0.59, Max: 0.64
Current: 0.62
0.42
0.64
Debt-to-Equity 0.09
Debt-to-Equity range over the past 10 years
Min: 0.09, Med: 0.29, Max: 0.91
Current: 0.09
0.09
0.91
Debt-to-EBITDA 0.39
Debt-to-EBITDA range over the past 10 years
Min: 0.39, Med: 1.74, Max: 3.8
Current: 0.39
0.39
3.8
Interest Coverage 15.70
Interest Coverage range over the past 10 years
Min: 1.1, Med: 3.27, Max: 15.7
Current: 15.7
1.1
15.7
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.63
DISTRESS
GREY
SAFE
Beneish M-Score -2.20
Not Manipulator
Manipulator

Profitability & Growth : 6/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 14.39
Operating Margin range over the past 10 years
Min: 8.32, Med: 14.34, Max: 21.57
Current: 14.39
8.32
21.57
Net Margin % 10.49
Net Margin range over the past 10 years
Min: -2.42, Med: 8.97, Max: 10.49
Current: 10.49
-2.42
10.49
ROE % 13.73
ROE range over the past 10 years
Min: -2.13, Med: 4.82, Max: 13.73
Current: 13.73
-2.13
13.73
ROA % 8.00
ROA range over the past 10 years
Min: -0.83, Med: 2.71, Max: 8
Current: 8
-0.83
8
ROC (Joel Greenblatt) % 217.69
ROC (Joel Greenblatt) range over the past 10 years
Min: 79.04, Med: 134.64, Max: 217.69
Current: 217.69
79.04
217.69
3-Year Total Revenue Growth Rate 25.20
3-Year Revenue Growth Rate range over the past 10 years
Min: 0, Med: 19, Max: 28.2
Current: 28.2
0
28.2
3-Year Total EBITDA Growth Rate 12.10
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 10.5, Max: 14.7
Current: 14.7
0
14.7

» MEDP's 30-Y Financials

Financials (Next Earnings Date: 2019-07-29)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:MEDP

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Diagnostics & Research » Medical Diagnostics & Research    NAICS : 541714    SIC : 8731
Compare NAS:KANG BSP:PARD3 SZSE:300685 NAS:AXDX SHSE:603108 NAS:VREX NAS:ALOG SHSE:600055 NAS:GHDX NSE:LALPATHLAB NAS:BEAT TSE:4694 SZSE:300439 SZSE:300396 TSE:4282 NAS:ABAX SZSE:300482 SHSE:603127 NAS:NRCIA HKSE:02393
Traded in other countries 01P.Germany
Address 5375 Medpace Way, Cincinnati, OH, USA, 45227
Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.

Ratios

Current vs industry vs history
PE Ratio (TTM) 29.80
PE Ratio range over the past 10 years
Min: 0.06, Med: 31.08, Max: 57.16
Current: 29.8
0.06
57.16
Forward PE Ratio 23.47
N/A
PE Ratio without NRI 29.80
PE without NRI range over the past 10 years
Min: 0.06, Med: 31.08, Max: 57.16
Current: 29.8
0.06
57.16
PB Ratio 3.68
PB Ratio range over the past 10 years
Min: 1.51, Med: 2.54, Max: 4.25
Current: 3.68
1.51
4.25
PS Ratio 3.07
PS Ratio range over the past 10 years
Min: 2.15, Med: 3.01, Max: 4.01
Current: 3.07
2.15
4.01
Price-to-Free-Cash-Flow 15.11
Price-to-Free-Cash-Flow range over the past 10 years
Min: 11.54, Med: 15.53, Max: 19.36
Current: 15.11
11.54
19.36
Price-to-Operating-Cash-Flow 13.87
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 10.39, Med: 13.58, Max: 17
Current: 13.87
10.39
17
EV-to-EBIT 21.14
EV-to-EBIT range over the past 10 years
Min: 18, Med: 23.95, Max: 32.3
Current: 21.14
18
32.3
EV-to-EBITDA 15.70
EV-to-EBITDA range over the past 10 years
Min: 9.8, Med: 14.3, Max: 19.6
Current: 15.7
9.8
19.6
EV-to-Revenue 3.00
EV-to-Revenue range over the past 10 years
Min: 2.5, Med: 3.3, Max: 4.2
Current: 3
2.5
4.2
Current Ratio 0.69
Current Ratio range over the past 10 years
Min: 0.66, Med: 0.7, Max: 0.86
Current: 0.69
0.66
0.86
Quick Ratio 0.69
Quick Ratio range over the past 10 years
Min: 0.66, Med: 0.7, Max: 0.86
Current: 0.69
0.66
0.86
Days Sales Outstanding 52.74
Days Sales Outstanding range over the past 10 years
Min: 39.64, Med: 42.94, Max: 52.74
Current: 52.74
39.64
52.74
Days Payable 9.61
Days Payable range over the past 10 years
Min: 9.61, Med: 15.84, Max: 23.28
Current: 9.61
9.61
23.28

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate 3.50
3-Year Share Buyback Rate range over the past 10 years
Min: -0.9, Med: 3.5, Max: 3.6
Current: 3.5
-0.9
3.6

Valuation & Return

Current vs industry vs history
Price-to-Median-PS-Value 1.04
Price-to-Median-PS-Value range over the past 10 years
Min: 0.9, Med: 0.96, Max: 1.18
Current: 1.04
0.9
1.18
Earnings Yield (Joel Greenblatt) % 4.77
Earnings Yield (Greenblatt) range over the past 10 years
Min: 3.1, Med: 4.2, Max: 5.6
Current: 4.77
3.1
5.6

More Statistics

Revenue (TTM) (Mil) $ 742.25
EPS (TTM) $ 2.09
Beta 0
Volatility % 61.85
52-Week Range $ 45.88 - 71.66
Shares Outstanding (Mil) 35.82

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y